Biotech fall leads to buying opportunitiy: Analyst

With the IBB performing poorly and increased confusion in the biotech market, is it time for investors to be bullish?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.